AnaptysBio, Inc. ANAB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s financing cash flow?
- AnaptysBio, Inc. (ANAB) reported financing cash flow of $1.21M in Q1 2026.
- How has AnaptysBio, Inc.'s financing cash flow changed year-over-year?
- AnaptysBio, Inc.'s financing cash flow increased by 104.2% year-over-year, from -$28.59M to $1.21M.
- What is the long-term trend for AnaptysBio, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s financing cash flow has grown at a -14.9% compound annual growth rate (CAGR), from $252.3M to -$132.61M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.